| Therapeutics |
| 05-0011 |
Ionic Liquids as a Platform for Active Biological, Pharmaceutical, and
Nutritional Ingredients with Improved Properties |
| 05-0024 |
Use of Triaqua -u3-Oxohexakis-u-Propionatotrichromium as a
Nutritional Supplement or in Treatment of Medical Conditions |
| 05-0025 |
Method of Decreasing Plasma Cholesterol and Triglycerides with a
Chromium-Containing complex |
| 05-0032 |
“Time-release" derivatives of the nutritional supplement and
therapeutic agent Cr3 |
| 05-0056 |
Method of Decreasing Plasma Cholesterol and Triglycerides with a
Chromium-Containing Complex |
| 05-0057 |
Method for Isolation of Bovine Low-Molecular Weight CR-Binding
Substance and Method of Use of the Same |
| 05-0059 |
Use of Triaqua-3-Oxohexakis-Propionatotrichromium, as a Nutritional
Supplement or in Treatment of Medical Conditions |
| 06-0003 |
New Synthesis of the nutritional supplement and therapeutic agent
Cr3 |
| 07-0029 |
Neuroprotection by Cathespin D |
| 07-0037 |
New genes which regulate protein misfolding and aggregation,
specified as F59F4.1, F55A4.1 and C54H2.5 |
